Acceleron Pharma to Ring the NASDAQ Stock Market Closing Bell
Published: Nov 04, 2013
ADVISORY, Nov. 4, 2013 (GLOBE NEWSWIRE) -- What: Acceleron Pharma Inc. [XLRN], a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of protein therapeutics to improve the lives of patients with cancer and rare diseases, will visit the NASDAQ MarketSite in Times Square.
Help employers find you! Check out all the jobs and post your resume.